Status:
COMPLETED
PCRC-Supported Legacy Intervention in Pediatric Palliative Care
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Palliative Care Research Cooperative Group
Conditions:
Care Giver
Recurrent Malignant Neoplasm
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
This trial studies how well a web-based legacy intervention works in improving the quality of life in caregivers and younger patients with cancer that has come back (recurrent) or does not respond to ...
Detailed Description
PRIMARY OBJECTIVES: I. To examine the impact of legacy-making on coping strategies and adjustment outcomes among children with refractory or relapsed cancer. II. To examine the impact of legacy-maki...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Children ages 7-17 years will be included so the sample will reflect similar developmental understandings that death is permanent and universal. Ages 18 and up are excluded because they begin very different developmental stages of independence as they often leave home and begin college and careers. The principal investigator (PI) or trained clinical trials associate (CTA) will determine the primary parent caregiver by gathering objective information (e.g., number of hours spent per week with the child) from the child's legal guardian during the initial recruitment process
- Relapsed or refractory cancer disease states: This will be determined by parent self-report. This determination will be made at any point within the illness trajectory
- Able to speak, understand, read, and type English: Participants will be limited to those who meet this criterion because the instruments and methods proposed in this research have not been translated in foreign languages
- Participants will be limited to those who have internet access to allow us to successfully examine the feasibility of a web-based intervention
- Absence of cognitive impairment: Cognitive impairment will be determined by the PI or CTA during the consent process. If the child or parent does not understand the consent process (e.g., does not understand project goal, does not understand study procedures), the PI or CTA will gently conclude the recruitment process. Any data already collected will not be included in data analysis, and the participant will be considered withdrawn
Exclusion
Key Trial Info
Start Date :
July 27 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04059393
Start Date
July 27 2015
End Date
June 5 2018
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232